TrialWatch

Find and recruit qualified investigators
using CenterWatch's large distribution network.


TrialWatch is a FREE service offered by CenterWatch to sponsor and CRO companies looking to supplement their site identification practices.

Pharmaceutical, biotechnology, medical device companies and CROs list brief notices of their upcoming or ongoing clinical trials that are actively seeking qualified investigative site candidates. Companies may also list their notices anonymously and CenterWatch will then compile and send materials to you.

Your notices will reach more than 25,000 experienced investigators who regularly read the CenterWatch Newsletter. Qualified investigators will then send you their CV's and other pertinent information upon reading the trial listing. Sponsors and CROs can typically expect to receive 40-60 responses for each listing they publish in TrialWatch.

  • **Important Notice: This service is not for patients. If you are a patient looking to participate in a clinical trial, please see our patient recruitment listings.

  • If you are a site interested in finding new trials, please see our CenterWatch Newsletter.

Please click on the appropriate button below to either submit your notice(s) today, or request additional information about this service.

Click the "Submit Notice" button to submit your trial information and begin finding investigators today.

Click the "Inquire Only" button to request more information about the TrialWatch service.



Back to Investigative Site Identification Services

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Careers & Education ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]

Copyright (c) 1995 - 2001, CenterWatch, Inc.
All Rights Reserved

This site was developed in association with Illumina Interactive of Boston, MA